We are technology-based specialty pharmaceutical company and a leader in the development, manufacturing and marketing of prescription pharmaceutical products utilizing our formulation expertise and unique drug delivery technologies. We are focused on utilizing our core competency in drug delivery expertise and formulation development to target high-value solid oral and alternative dosage form (ADF) Abbreviated New Drug Applications (ANDAs) that are difficult to develop and that bring sustainable profitability. Key Features are 1. RESEARCH & DEVELOPMENT 2. STATE-OF -THE-ART MANUFACTURING FACILITIES AND TECHNOLOGY 3. QUALIFIED & EXPERIENCED TEAM
| Website | http://mediatepharma.com/ |
| Revenue | $1 million |
| Employees | 33 (22 on RocketReach) |
| Founded | 2004 |
| Address | Plot 150-151 Sector 24 Korangi Industrial Area, Karachi, Sindh 75000, PK |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Products, Pharma, Prescription Drugs, Drug Delivery, Specialty Pharmaceuticals, Pharmaceutical Development, Pharmaceutical Manufacturing, Drug Formulation, Prescription Medications, Drug Research, New Drug Development, Pharmaceutical Marketing, Pharmaceutical Sales, Clinical Trials, Fda Approval, Drug Patents, Generic Drugs |
| Competitors | Roche, Pfizer, Amgen, Thermo Fisher Scientific, Novartis, Sanofi, Lonza, Biogen, Sartorius, MilliporeSigma +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Mediate Pharma employee's phone or email?
The Mediate Pharma annual revenue was $1 million in 2026.
Babar Solangi is the Procurement Executive of Mediate Pharma.
22 people are employed at Mediate Pharma.
Mediate Pharma is based in Karachi, Sindh.
The NAICS codes for Mediate Pharma are [3254, 32541, 32, 325].
The SIC codes for Mediate Pharma are [283, 28].